What is Depression

Depression is a neurological condition in which a person feels discouraged, sad, hopeless, unmotivated, or disinterested in life in general. The feelings are so severe that they interfere with the person’s daily activities such as taking care of family, spending time with friends, or going to work or school. There are three main types of depressive disorders – major depression, dysthymia, and bipolar disorder. In major depression, the person suffers from at least five symptoms for a two-week period. Major depressive episodes can happen once or twice in life or even frequently and are likely to interfere with the ability to work, study, eat, and sleep. Dysthymia is a less severe, long-term, and chronic form of depression that involves the same symptoms as major depression, such as low energy, poor appetite or overeating, and insomnia or oversleeping. Bipolar disorder is characterized by mood cycles that shift from severe highs (mania) or mild highs (hypomania) to severe lows (depression).

According to WHO (World Health Organization), depression affects an estimated 350 million people across the world, with depression-related suicides causing an estimated 1 million deaths annually. Studies have revealed that over 80% of people with symptoms of clinical depression are not receiving any treatment for their depression.

 

What Causes Depression

Advances in technology that help us precisely understand how the brain works have shown that there is reduced blood flow to various areas of the cerebral cortex in the brain in patients with depression. Scientists have discovered that individuals in a depressed emotional state have impaired cerebral (brain) blood flow. Cerebral blood flow in depressed patients is often lower in comparison to healthy people, especially in the brain’s cerebral cortex. In fact, studies have revealed that clinical improvement in depression is accompanied by diverse changes in cerebral blood flow, whatever may have been the method of treatment. Cerebral blood flow abnormalities also explain the vulnerability to relapse in patients recovered from major depression, as blood flow in the cerebral cortex remains abnormal even in patients who have recovered from major depression.

Research suggests that depression can actually shrink parts of the brain. Brain-imaging studies, post-mortem examinations of human brains and animal studies have all found that in depression, a part of the brain called the dorsolateral prefrontal cortex shrinks. The neurons in this region, which is responsible for complex tasks from memory and sensory integration to the planning of actions, are also smaller and less dense in depressed people compared with healthy people.

 

Cerebra’s Treatment for Depression

Cerebra TurboBrain’s revolutionary Brain Enhancement Technology, which increases blood flow to the brain, is based on the science of Hemoencephalography, or the measurement of voluntarily-controlled regional blood flow in the brain. Using a specially adapted controller in conjunction with a computer for active, real-time viewing of one’s brain activity measured through Cerebral Blood Flow, Cerebra TurboBrain targets the prefrontal cortex by modifying the on-screen activity – viewing based on cerebral blood flow activity. By effectively maintaining abundant cerebral blood flow that is required to provide a constant supply of oxygen, glucose, and other nutrients for the brain to function properly, Cerebra TurboBrain cures depression, as well as enhances cognitive abilities. Individuals suffering from depression can benefit hugely from Cerebra TurboBrain’s cerebral blood flow measuring technology, by becoming free from the symptoms associated with the disorder, as well as vastly improving their focus, attention, memory, social behavior, prioritizing, multi-tasking, reduced stress and anxiety.

Cerebra’s suite of brain enhancement and regeneration technologies also includes Cerebra PhotoBioStim (CPBS), which uses coherent light to directly stimulate affected areas in the brain, all over the scalp. The basic biochemical pathways activated by CPBS, e.g., increased ATP production, and signaling pathways activated by reactive oxygen species, nitric oxide release, and increased cyclic adenosine monophosphate (AMP), all work together to produce beneficial effects in brains whose function has been compromised by depression-related neurodegeneration.

Both CTB and CPBS offer great potential in the resolution of depression and are already delivering promising results for affected people across Asia, including Mumbai and New Delhi. Please visit the Scientific Research section in the website to read about the vast amount of studies that is being done on CTB and CPBS technologies.

 

Why Early Intervention Is Important In Treatment for Depression

Depression not only makes a person feel sad and dejected, but can also damage the brain permanently. Depression, even in the most severe cases, can be effectively treated and the earlier the treatment is started, the more effective it is. Research has shown that the longer one waits to treat the disorder, the greater will be the impairment.

Depression can cause long-term damage to the brain unless there is early intervention, which is vital in order to retain cognitive functions and improve the quality of life. This makes it vital for individuals suffering from depression to seek timely treatment with CTB and CPBS training before irreversible brain damage occurs

Please visit the Success Stories section in the website to read heart-warming testimonials of the remarkable benefits being experienced by individuals after undergoing CTB and CPBS training.